2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The choroid plexus is a key cerebral invasion route for T cells after stroke.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Neuroinflammation contributes substantially to stroke pathophysiology. Cerebral invasion of peripheral leukocytes-particularly T cells-has been shown to be a key event promoting inflammatory tissue damage after stroke. While previous research has focused on the vascular invasion of T cells into the ischemic brain, the choroid plexus (ChP) as an alternative cerebral T-cell invasion route after stroke has not been investigated. We here report specific accumulation of T cells in the peri-infarct cortex and detection of T cells as the predominant population in the ipsilateral ChP in mice as well as in human post-stroke autopsy samples. T-cell migration from the ChP to the peri-infarct cortex was confirmed by in vivo cell tracking of photoactivated T cells. In turn, significantly less T cells invaded the ischemic brain after photothrombotic lesion of the ipsilateral ChP and in a stroke model encompassing ChP ischemia. We detected a gradient of CCR2 ligands as the potential driving force and characterized the neuroanatomical pathway for the intracerebral migration. In summary, our study demonstrates that the ChP is a key invasion route for post-stroke cerebral T-cell invasion and describes a CCR2-ligand gradient between cortex and ChP as the potential driving mechanism for this invasion route.

          Related collections

          Author and article information

          Journal
          Acta Neuropathol.
          Acta neuropathologica
          Springer Nature
          1432-0533
          0001-6322
          Dec 2017
          : 134
          : 6
          Affiliations
          [1 ] Institute for Stroke and Dementia Research, Klinikum der Universität München, Feodor-Lynen-Str. 17, 81377, Munich, Germany.
          [2 ] Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
          [3 ] Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.
          [4 ] Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität, Feodor-Lynen-Str. 23, 81377, Munich, Germany.
          [5 ] Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität, Nussbaumstraße 7, 80336, Munich, Germany.
          [6 ] Institute of Clinical Neuroimmunology, Klinikum der Universität München, Ludwig-Maximilians-University, Grosshaderner Str. 9, 82152, Munich, Germany.
          [7 ] INSERM, UMR-S U919, Institut National de la Santé Et de la Recherche Médicale (INSERM), Team Serine Proteases and Pathophysiology of the Neurovascular Unit, GIP CYCERON, University Caen Basse-Normandie, 14074, Caen Cedex, France.
          [8 ] Neurovascular Research Laboratory, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
          [9 ] Institute for Stroke and Dementia Research, Klinikum der Universität München, Feodor-Lynen-Str. 17, 81377, Munich, Germany. Arthur.Liesz@med.uni-muenchen.de.
          [10 ] Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. Arthur.Liesz@med.uni-muenchen.de.
          Article
          10.1007/s00401-017-1758-y
          10.1007/s00401-017-1758-y
          28762187
          0f48038a-1c53-46e0-a706-9802f5b1165a
          History

          Comments

          Comment on this article